SciELO - Scientific Electronic Library Online

vol.84 suppl.1Aproximación a los valores de referencia de la capacidad residual funcional en una población de niños y adolescentesComplicaciones microvasculares en niños con diabetes mellitus tipo I author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links


Archivos de Pediatría del Uruguay

On-line version ISSN 1688-1249


TEJERA, Jonathan; PUJADAS, Mónica; ALONSO, Bernardo  and  PIREZ, Catalina. Aplicación de oxigenoterapia de alto flujo en niños con bronquiolitis e insuficiencia respiratoria en piso de internación: Primera experiencia a nivel nacional. Arch. Pediatr. Urug. [online]. 2013, vol.84, suppl.1, pp.28-33. ISSN 1688-1249.

Objective: to analyze the clinical characteristics and outcome of children with bronchiolitis and moderate respiratory insufficiency treated with High Flow Therapy (HFT) in the July-September period of 2011 and 2012. Methodology: prospective study of patients hospitalized with bronchiolitis treated with HFT (Fisher & Paykel ® system). We included 23 patients in total who met the selection criteria, evaluating clinical parameters and cardiorespiratory hourly during treatment. Results: we included 23 patients, median age was 2 months (range 11 days to 13 months) 74% of them were positive VRS. Indications for HFT were modified Tal’s Score ³ 8 to start or ³ 6 held for more than two hours of treatment. Average hours of HFT was 58 hours (range 12 to 120). The technique produced a decrease in respiratory frequency and the modified Tal’s Score 2 hours after treatment, which in turn was statistically significant, with no observed adverse effects. Admitted to intensive care unit (PICU) 5 patients (22%), so it was avoided by 78% of the proceeds to that unit with this technique, in this group of patients. Discussion: the HFT clinical improvement is achieved through its impact on respiratory function syndrome as well as modified Tal’s Score in children with bronchiolitis. Allows management of these patients in moderate care sector, with few adverse effects, reducing admission to intensive care.


        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License